For individuals who are candidates for GLP-1 therapies, joining a study may offer new hope when other weight loss methods have not yielded the desired results
Prescribing decisions must be made by a qualified clinician according to the licensed indication, clinical need and current guidance
Studies on healthy adults found that CJC-1295 caused sustained, dose-dependent increases in GH and IGF-1, with no serious adverse effects noted
A Pill With Promise and Perspective Experts urge cautious optimism. While the results are exciting, oral GLP-1s arent magic bullets
Take the free assessment quiz today and start your journey toward a healthier, more vibrant life with the support you deserve
To view or add a comment, sign in In clinical practice, physicians frequently encounter patients at high cardiovascular risk who decline statin therapy due to concerns about potential increases in blood glucose levels and the development of diabetes